[On the treatment of the digitalis-induced atrial tachycardia with AV conduction disorder. Experiences with sodium-magnesium aspartate].
D000328:Adult; D001224:Aspartic Acid / Q000008:administration & dosage*; D004074:Digitoxin / Q000009:adverse effects* / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006327:Heart Block / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D008274:Magnesium / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D012964:Sodium / Q000008:administration & dosage*; D013610:Tachycardia / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*
D001224:Aspartic Acid; D012964:Sodium; D004074:Digitoxin; D008274:Magnesium
Zur Therapie der digitalisinduzierten Vorhoftachykardie mit AV-Uberleitungsstörung. Erfahrungen mit Kalium-Nagnesium-aspartat.